Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India
· Delayed Price · Currency is INR 72.00
-3.34 (-4.43%)
May 9, 2025, 1:39 PM IST
Bafna Pharmaceuticals Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 1.70 billion as of May 9, 2025. Its market cap has decreased by -17.86% in one year.
Market Cap
1.70B
Enterprise Value
1.88B
Revenue
1.48B
Ranking
n/a
PE Ratio
39.66
Stock Price
72.00
Market Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 1.70B, an increase of 15,552.17%. That is a compound annual growth rate of 164.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 1.70B | -8.75% |
| Dec 31, 2024 | 1.87B | -14.24% |
| Dec 29, 2023 | 2.18B | -8.68% |
| Dec 30, 2022 | 2.38B | -33.96% |
| Dec 31, 2021 | 3.61B | -10.71% |
| Dec 31, 2020 | 4.04B | 37,041.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,273.94B |
| Divi's Laboratories | 1,635.55B |
| Cipla | 1,220.67B |
| Apollo Hospitals Enterprise | 1,007.79B |
| Mankind Pharma | 1,003.56B |
| Zydus Lifesciences | 886.14B |
| Aurobindo Pharma | 695.28B |
| Alkem Laboratories | 600.63B |